MDNA Stock Price, News & Analysis

MDNA NASDAQ

Company Description

MDNA (NASDAQ: MDNA) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

MDNA stock has declined 38.6% over the past year.

This page provides a comprehensive overview of MDNA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-38.57%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

MDNA (MDNA) stock. Over the past 12 months, the stock has lost 38.6%.

Latest News

View All

November 9, 2023

+14.54%

Medicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp Survival Data in Recurrent Glioblastoma at the Society for Neuro-Oncology 2023 Annual Meeting

conferences clinical trial

November 6, 2023

+22.52%

Medicenna Announces Promising Single-Agent Response and Durability of MDNA11 in the Phase 1/2 ABILITY Study During Dose Escalation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

clinical trial

November 3, 2023

+48.02%

Medicenna Presents Preclinical Data on MDNA113, its Targeted Metalloprotease Activated SuperKine (T-MASK) at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

clinical trial

October 27, 2023

-21.24%

Medicenna Announces Nasdaq Delisting and Cutback of Management Team

October 25, 2023

-5.04%

Medicenna Therapeutics Doses First Patient in Phase 2 Monotherapy Dose Expansion Portion of the ABILITY Study Evaluating MDNA11 in Select Types of Solid Tumors

clinical trial

October 24, 2023

-2.84%

Medicenna Announces Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer’s (SITC)

MDNA has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, clinical trial, management. View all MDNA news →

SEC Filings

View All

No SEC filings available for MDNA.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

MDNA Company Profile & Sector Positioning

MDNA (MDNA) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.